Scientific Publication

Artemisinin combination therapies: policy and market surveys in Burundi and Sierra Leone

author(s) Diap, G.. - Boakye, I.. - Amuasi, J.H.. - Karikari, Y.. - Deley, A.. - Blay, S.. - Karenzo, J.. - Nsabiyumva, L.. - Jambai, A.. - Baker, S.
from UK Foreign, Commonwealth & Development Office (FCDO)
permalink open
themes
regions
  • Western Africa
  • Sub-Saharan Africa
  • Africa
  • World
  • Eastern Africa
citation

Amuasi, J.H.; Karikari, Y.; Boakye, I.; Deley, A.; Blay, S.; Karenzo, J.; Nsabiyumva, L.; Jambai, A.; Baker, S.; Diap, G. Artemisinin combination therapies: policy and market surveys in Burundi and Sierra Leone. Presented at The American Society of Tropical Medicine and Hygiene 58th Annual Meeting, Washington, DC, USA, 18-22 November 2009. (2009)

Publications and datasets provided via GARDIAN

Abstract

To ensure that the new antimalarial formulation ASAQ (artesunate + amodiaquine) for treatment of uncompliated Plasmodium falciparum malaria became rapidly and widely acessible to patients following its launch, DNDi conducted a policy and market survey in 6 African countries that had already adopted ASAQ as first-line treatment; data from 2 countries were available at the time of writing. It was concluded that more needed to be done to improve availability of the treatment

Open original